Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1996
10/03/1996WO1996029986A1 Antitussive microcapsules
10/03/1996WO1996029985A1 Butixocort aerosol formulations
10/03/1996WO1996029984A1 Sterile ophthalmological gel preparation applicable in drops and process for producing it
10/03/1996WO1996029982A1 Cosmetic and/or pharmaceutical preparations
10/03/1996WO1996029974A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996WO1996029973A2 Compositions and methods for inhibiting thrombogenesis
10/03/1996WO1996029867A2 Fast acting and persistent topical antiseptic
10/03/1996WO1996026285A3 Methods and compositions for administering gene therapy vectors
10/03/1996WO1996026196A3 Benzylpiperidines and piperazines as muscarinic antagonists
10/03/1996WO1996024348A3 Use of carbazole compounds for the treatment of congestive heart failure
10/03/1996WO1996023489A3 Use of carotinoids for preparing medicaments for treating dermatoses
10/03/1996WO1996013498A3 L-erythrosyl nucleosides
10/03/1996WO1994004702A3 Improved detection and therapy of lesions with biotin/avidin conjugates
10/03/1996CA2588767A1 Hapten-carrier conjugates for use in drug-abuse therapy
10/03/1996CA2216835A1 Human g-protein coupled receptors
10/03/1996CA2216728A1 Azathioprine compositions for colonic administration
10/03/1996CA2216707A1 Inhibitors of farnesyl-protein transferase
10/03/1996CA2216651A1 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996CA2216647A1 Pharmaceutical agents containing methotrexate derivatives
10/03/1996CA2216564A1 Inhibitors of farnesyl-protein transferase
10/03/1996CA2216526A1 Inhibitors of farnesyl-protein transferase
10/03/1996CA2216381A1 Radiosensitizing diamines and their pharmaceutical preparations
10/03/1996CA2216278A1 Transdermally administrable medicament with ace inhibitors
10/03/1996CA2216151A1 Reversible protease inhibitors
10/03/1996CA2215720A1 .beta.-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
10/03/1996CA2215711A1 Lidocaine-vasoconstrictor aerosol preparation
10/03/1996CA2215330A1 Methods of treating disorders of the eye
10/03/1996CA2215256A1 Transdermal device for the delivery of alfuzosin
10/03/1996CA2215255A1 Butixocort aerosol formulations
10/03/1996CA2215245A1 Inhibitors of metazoan parasite proteases
10/03/1996CA2215211A1 Cysteine protease inhibitor
10/03/1996CA2215160A1 Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases
10/03/1996CA2214464A1 Method of treating or preventing non-viral microbial infection
10/03/1996CA2190185A1 Polymorphs a and b of 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl) propyl]piperazine
10/02/1996EP0735141A2 Process for preparation of benzo(b)thiophene glucuronides
10/02/1996EP0735046A1 Oligonucleotide and carcinostatic agent containing the same as active ingredient
10/02/1996EP0735045A1 Process for the preparation of 2,2'-andhydro- and 2'-keto-1-(3',5'-di-o-protected-beta -d-arabinofuranosyl) nucleosides
10/02/1996EP0735044A1 Preparation of D4T from 5-methyluridine
10/02/1996EP0735042A1 Maltitol composition and its process of preparation
10/02/1996EP0735041A1 New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof
10/02/1996EP0735040A2 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation
10/02/1996EP0735038A1 Protein kinase C inhibitors
10/02/1996EP0735031A1 N-acetylpiperazine derivative, antibacterial drug, and anti-ulcer drug
10/02/1996EP0735024A1 Antidepressant N-(Heteroarylaminoalkyl)-4-napthyl substituted piperidines and tetrahydroperidines
10/02/1996EP0735019A2 Retroviral protease inhibitors
10/02/1996EP0734729A1 Use of a CGRP antagonist for the treatment of cutaneous erythema of neurogenic origin and so obtained composition
10/02/1996EP0734728A1 Use of a CGRP antagonist for the treatment of lichens and pruritis and composition so obtained
10/02/1996EP0734724A1 A composition for preventing and treating kinetotia syndrome
10/02/1996EP0734723A1 Therapeutic composition for hyperparathyroidism of patient subjected to artificial dialysis
10/02/1996EP0734721A2 Method of incorporating drugs into a polymer component of stents
10/02/1996EP0734718A2 Use of N-acetyl-L-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
10/02/1996EP0734453A1 Phenylserine amides and the preparation of phenylserines/phenylserine amides
10/02/1996EP0734448A1 Gene therapy for restenosis using an adenoviral vector
10/02/1996EP0734439A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
10/02/1996EP0734436A1 Inhibition of dna methyltransferase
10/02/1996EP0734391A1 Pna-dna-pna chimeric macromolecules
10/02/1996EP0734389A1 Rapamycin derivatives useful as immunosuppressants
10/02/1996EP0734388A1 IMPROVED PROCESS FOR THE SYNTHESIS OF 2-AMINO-3,5-DIHYDRO-7-SUBSTITUTED-4H-PYRROLO[3,2-d]PYRIMIDIN-4-ONES
10/02/1996EP0734387A1 Hiv protease inhibitors
10/02/1996EP0734386A1 Platelet activating factor antagonists: imidazopyridine indoles
10/02/1996EP0734384A1 3-substituted 1-arylindole compounds
10/02/1996EP0734383A1 Cyclic amide derivatives as neurokinin a antagonists
10/02/1996EP0734382A1 Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation
10/02/1996EP0734381A1 Morpholine and thiomorpholine tachykinin receptor antagonists
10/02/1996EP0734379A1 Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
10/02/1996EP0734378A1 Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
10/02/1996EP0734376A1 Vitamin d amine and amide derivatives
10/02/1996EP0734374A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
10/02/1996EP0734373A1 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them
10/02/1996EP0734371A1 Novel retinoid conjugate compounds and methods for treating skin aging
10/02/1996EP0734285A1 Deep-bed filter for exterminating micro-organisms and inactivating viruses and its use
10/02/1996EP0734267A1 Aqueous topical compositions
10/02/1996EP0734264A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
10/02/1996EP0734262A1 Use of pentoxifyllin in the treatment of multiple sclerosis
10/02/1996EP0734261A1 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
10/02/1996EP0734260A1 Paroxetine tablets and process to prepare them
10/02/1996EP0734259A1 Antipsychotic method
10/02/1996EP0734258A1 Anthelmintic composition containing rafoxanide and fenbendazole
10/02/1996EP0734257A1 Pharmaceutical compositions for topical use containing (s)-2-(4-isobutylphenyl)propionic acid
10/02/1996EP0734256A1 Di-tert-butylphenol compounds useful as anti-inflammatory agents
10/02/1996EP0734255A1 Novel potassium channel agonist produced from trichoderma virens
10/02/1996EP0734252A1 Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties
10/02/1996EP0734249A1 Novel and improved aminoglycoside formulation for aerosolization
10/02/1996EP0734248A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
10/02/1996EP0734209A1 Growth promoting composition for fish
10/02/1996EP0663812B1 Use of alkylpolyglycosides and/or o-acylated derivatives of glucose for treating hair loss
10/02/1996EP0653943A4 Targeting somatic gene therapy to joints.
10/02/1996EP0648121B1 Use of rifamycin derivatives for the manufacture of a medicament for the treatment of toxoplasmosis
10/02/1996EP0645056B1 Micromechanical thermoelectric sensor element
10/02/1996EP0575497B1 Dna sequences which code for virulence characteristics of -$(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by -$(s. suis) in mammals, including man
10/02/1996EP0538476B1 Preventive or remedy for ischemia, reperfusion-induced tissue disorder and arrhythmia as well as pulmonary disorder caused by activated oxygen free radical
10/02/1996EP0538348B1 UNSATURATED 15-DEHYDRO-17alpha-CYANOMETHYL-17beta- HYDROXYSTEROIDS
10/02/1996EP0527975B1 Codeinone derivatives and their pharmaceutical use
10/02/1996EP0489181B1 Solid preparation
10/02/1996EP0480054B1 Percutaneously absorbable composition of morphine hydrochloride
10/02/1996EP0471794B1 Antiviral therapy using thiazine and xanthene dyes
10/02/1996EP0275285B1 Biodegradable superparamagnetic materials used in clinical applications
10/02/1996DE19513040A1 Neue Borneolester, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New Borneo Lester, processes for their preparation and their pharmaceutical use
10/02/1996DE19512181A1 Transdermal applizierbares Arzneimittel mit ACE-Hemmern Transdermally administrable drug with ACE inhibitors
10/02/1996DE19511637A1 Kosmetische und/oder pharmazeutische Zubereitungen Cosmetic and / or pharmaceutical preparations
1 ... 6874 6875 6876 6877 6878 6879 6880 6881 6882 6883 6884 6885 6886 6887 6888 6889 6890 6891 6892 6893 6894 ... 7860